A phase I trial of nab-paclitaxel/bevacizumab (AB160) nano-immunoconjugate therapy for metastatic gynecological malignancies: MC1371 (NCT02020707).
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Eleftheria Kalogera, Vera Jean Suman, Wendy Kay Nevala, Heidi Diann Finnes, Jill Schimke, Carrie Strand, Gretchen Glaser, Megan Grudem, Aminah Jatoi, Carolyn Klampe, Amanika Kumar, Carrie L Langstraat, Andrea Elisabeth Wahner Hendrickson, Saravut John Weroha, Joel M. Reid, Svetomir Markovic, Matthew Stephen Block
Institution: Mayo Clinic
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W3032099224